Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Nausea: early-phase trial registry
7 of 18 indexed Nausea trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #953 of 28,707 conditions by registered trial count.
18 US clinical trials · 7 currently recruiting · #953 of 28,707 conditions by registered trial count
Nausea: 18 US clinical trials tracked, 7 recruiting.
Nausea is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Montefiore Medical Center, running 2 of these trials.
Enrollment posture brief
Registry condition nausea
OPEN 7 | RECR 39% | LATE 3 | EARLY 7 | RANK #953 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Chronic Myeloid Leukemia (39% recruiting · 36 trials)
Nausea lists 7 open slots (39% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Nausea on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Nausea is recruiting below its size-band peers.
7 of 18 indexed trials (38.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Nausea trials is spread across many organizations.
Montefiore Medical Center accounts for 2 of 18 trials (11.1%). 16 distinct sponsors appear on at least one study for this condition label.
-
Typical Nausea enrolment sits around 122 participants.
Median target enrolment is 122 among the 18 trials that report a genuine target (sentinel values excluded). 7 of those (38.9%) plan for fewer than 100 participants.
-
Nausea research is mostly interventional.
16 interventional and 2 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
18 total, page 1 of 1
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
Montefiore Medical Center
NCT06382012
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
NCT07169851
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
The Hospital for Sick Children
NCT03118986
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Enterra Medical
NCT06464926
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
University of Minnesota
NCT07378839
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
Christopher C. Thompson, MD, MSc
NCT06543316
Inhaled Isopropyl Alcohol for Treatment of Nausea
State University of New York at Buffalo
NCT05418244
Noninvasive Markers of Functional Nausea in Children
Vanderbilt University Medical Center
NCT03593811
Acupressure Wristbands for GLP-1RA Related Nausea
Florencia Ziemke
NCT06939517
Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)
University of California, San Francisco
NCT00514878
The Montefiore Metoclopramide Study
Montefiore Medical Center
NCT00475306
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Cedars-Sinai Medical Center
NCT02436057
Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting
Sergio Bergese
NCT01474915
Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department
Brooke Army Medical Center
NCT02760069
Acupressure and Relaxation for Nausea Control
University of Rochester
NCT00243269
Post- Surgery Recovery: Nerve Blocks w/ Sedation vs. Nerve Block w/ Either Sedation/Gen. Anesthesia
Hospital for Special Surgery, New York
NCT02602080
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
M.D. Anderson Cancer Center
NCT03040726
Virtual Reality at End-of-life
State University of New York at Buffalo
NCT06149429
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Nausea records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Nausea trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Nausea page
18 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Nausea trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Montefiore Medical Center sponsors the most Nausea trials on record, review their full trial history before evaluating a specific study. See Montefiore Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nausea condition card totals 18 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.